Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Accelerating Discovery & Development

We empower scientific decision-makers from the world’s most innovative biopharma organisations to make informed pipeline decisions in early R&D, accelerating their route from target ID to novel clinical candidate

Events

Community

Services

Resources

PLUS Pass

In-Person Events

01 - 02 Jul 2025 | Basel, Switzerland

Pushing traditional boundaries in pharmaceutical science by accelerating the discovery & development of novel therapeutics

02 - 03 Oct 2025 | San Diego, CA

Uniting North American biopharma decision-makers to innovate at speed, equipping them with the critical intelligence & partners they require to make informed pipeline decisions in early-stage R&D
View all Oxford Global Events

Online Events & Activities

Science Exchange
26/06/24, 16:00 BST | 8:00 PT
Controlled Release Formulations
View all Online Activities

Discovery & Development & Our Community

We connect biopharma leaders with the cross-industry stakeholders they require to discover and develop high-potential drug candidates. Our community extends across the entire early R&D ecosystem, from target discovery and lead optimisation through to drug formulation and preclinical research.

About Discovery & Development

Who We Serve

Partners

Our In-Person & Digital Services

We work with cutting-edge vendors within drug development, supporting them to forge in-depth connections with customers, showcase their solutions and position themselves as market leaders.

In-Person Services

Digital Marketing Services

Featured Resources

Latest Resources

AI/ML

BiomedGPT: Adopting a Generalist Approach to Biomedical AI

11/11/24 - BiomedGPT, a versatile AI tool used for biomedical research demonstrated impressive results across a wide range of healthcare tasks.

The Application of RNAi Therapeutics for Cardiovascular Disease Treatment

07/11/24 - Alnylam Pharmaceuticals explores the possibility of treating cardiovascular disease with RNAi therapeutics.

AI/ML Advancements in Drug Formulation – The Potential of Self-Driving Labs

16/10/24 - Intrepid Labs demonstrates how its self-driving lab uses ML and robotics to advance drug formulation.
View all Resources

Oxford Global PLUS Pass

Tailored for senior biopharma leaders & scientists, the PLUS Pass is your exclusive, all access gateway to 12 months of flagship conferences, online events and insightful content.

You’ll gain priority access to all Oxford Global events across not just the Discovery & Development brand, but our NextGen Biomed and Precision Medicine brands as well – from in-person events in the UK, Europe and USA to our regular online symposiums, webinars and group discussions, each designed to provide a productive environment for knowledge-sharing and networking. Plus, our PLUS Platform hosts a wealth of on-demand event recordings, content articles and industry news to help you keep your finger on the pulse of emerging industry trends and technology advancements year-round.

More Information